Moderna (MRNA) Tops Q2 EPS by 4c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Moderna Reports Second Quarter 2020 Financial Results and Provides Business Updates
August 5, 2020 7:00 AM EDTEnded quarter with $3.1 billion in cash, cash equivalents and investments
Moderna has received approximately $400 million of customer deposits as of July 31, 2020 for potential supply of mRNA-1273
Moderna updates 2020 guidance to reflect investments into mRNA-1273; the Company now expects net cash used in operating activities and for purchases of property and equipment to be between $0.65 to $0.85 billion, including the benefit of customer deposits received as of July 31, 2020
Phase 3 study of mRNA-1273 being conducted in collaboration with NIH and BARDA on track to complete... More
